Live Breaking News & Updates on Philipp Rosenbaum

Stay updated with breaking news from Philipp rosenbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19 Vaccines Deliver Herd Immunity


COVID-19 Vaccination in India: Issues and Challenges
India s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.
Mucormycosis (Black Fungal Disease)
Mucormycosis is spread by spores from the black fungus, Mycormycetes. It mainly affects people with a weak immune system and attacks the lungs and other organs of the body. It is also known as Black Fungal Disease. ....

Philipp Rosenbaum , Biontech Comirnaty , Drug Administration , Senior Pharma Analyst , Global Data , Covid 19 Vaccine , Broad Immunity , Single Dose , பிலிப் ரோசன்பாம் , மூத்தவர் பார்மா ஆய்வாளர் , உலகளாவிய தகவல்கள் , பரந்த நோய் எதிர்ப்பு சக்தி , ஒற்றை டோஸ் ,

Joe Biden Unveils $20 Billion For Vaccination Program


Joe Biden Unveils $20 Billion For Vaccination Program
by Angela Mohan on 
January 19, 2021 at 11:21 AM
Biden promises $20 billion for COVID-19 vaccination program, but new ideas may be needed for vaccine delivery.
Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst at GlobalData, a leading data and analytics company, offers his view on Biden s promise of $20 billion for vaccination program.
More funding for the mass rollout of COVID-19 vaccines is urgently needed, as the US reported on average 240,000 new daily confirmed COVID-19 cases and more than 3,300 deaths per day over the past week.
While hospitals and healthcare personnel on the ground are inundated with new COVID-19 cases, little capacity is left for vaccinations. ....

Philipp Rosenbaum , Senior Infectious Diseases Analyst , Covid 19 , 20 Billion , Global Data , Vaccination Program , Sars Cov 2 , Modern Healthcare Systems , பிலிப் ரோசன்பாம் , மூத்தவர் தொற்று நோய்கள் ஆய்வாளர் , உலகளாவிய தகவல்கள் , தடுப்பூசி ப்ரோக்ர்யாம் , நவீன சுகாதாரம் அமைப்புகள் ,